Calmodulin Is Essential for Estrogen Receptor Interaction with Its Motif and Activation of Responsive Promoter

This publication has 37 references indexed in Scilit:

• Differential Display of Reticulocalbin in the Highly Invasive Cell Line, MDA-MB-435, versus the Poorly Invasive Cell Line, MCF-7
  Biochemical and Biophysical Research Communications, 1997
• Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors
  Cancer Letters, 1995
• A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture
  Biochemical Pharmacology, 1994
• Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin
  Biochemical and Biophysical Research Communications, 1992
• Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.
  Proceedings of the National Academy of Sciences, 1992
• Calmodulin levels in oestrogen receptor positive and negative human breast tumours
  British Journal of Cancer, 1991
• Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells.
  Proceedings of the National Academy of Sciences, 1990
• Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine.
  Proceedings of the National Academy of Sciences, 1984
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
  Biochemical and Biophysical Research Communications, 1984
• Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13
  Cancer Chemotherapy and Pharmacology, 1983